2021 annual financial data
Coya Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -4,870,310 USD and net income was -4,891,792 USD.
Operating cash flow was -3,903,268 USD.
Get free Coya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,870,310 USD
- Net income
- -4,891,792 USD
- Operating cash flow
- -3,903,268 USD